Skip to main content

Table 4 Cell adhesion molecules VEGF concentrations before bone marrow cell application: subgroup analysis (n = 45)

From: Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia

 

All patients (n = 45)

Surviving patients with limb salvage (n = 31)

Death or major limb amputation (n = 14)

p value

sICAM-1 (ng/ml)

688 ± 287

738 ± 311

569 ± 181

0.03

sICAM-3 (ng/ml)

127 ± 76

126 ± 64

129 ± 101

0.93

sE-selectin (ng/ml)

125 ± 53

137 ± 54

98 ± 41

0.01

sP-selectin (ng/ml)

804 ± 620

818 ± 696

771 ± 429

0.78

sPECAM-1 (ng/ml)

419 ± 151

391 ± 144

481 ± 152

0.07

VEGF (pg/ml)

168 ± 183

185 ± 187

130 ± 170

0.34

  1. s soluble, ICAM intercellular adhesion molecule, VEGF vascular endothelial growth factor, PECAM platelet endothelial cell adhesion molecule, E-selectin endothelial–leukocyte adhesion molecule, P-selectin platelets activating adhesion molecule